Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia

Abstract
Malaria in Zambia accounts for about 4 million clinical cases and 8 000 deaths annually. Artemether-lumefantrine (ACT), a relatively expensive drug, is being used as first line treatment of uncomplicated malaria. However, diagnostic capacity in Zambia is low, leading to potentially avoidable wastage of drugs due to unnecessary anti malarial treatment.

This publication has 16 references indexed in Scilit: